Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial.
Poole-Wilson PA, Lubsen J, Kirwan BA, van Dalen FJ, Wagener G, Danchin N, Just H, Fox KA, Pocock SJ, Clayton TC, Motro M, Parker JD, Bourassa MG, Dart AM, Hildebrandt P, Hjalmarson A, Kragten JA, Molhoek GP, Otterstad JE, Seabra-Gomes R, Soler-Soler J, Weber S; Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators. Poole-Wilson PA, et al. Among authors: van dalen fj. Lancet. 2004 Sep 4-10;364(9437):849-57. doi: 10.1016/S0140-6736(04)16980-8. Lancet. 2004. PMID: 15351192 Clinical Trial.
Safety of nifedipine GITS in stable angina: the ACTION trial.
Poole-Wilson PA, Kirwan BA, Vokó Z, de Brouwer S, van Dalen FJ, Lubsen J; ACTION Investigators. Poole-Wilson PA, et al. Among authors: van dalen fj. Cardiovasc Drugs Ther. 2006 Feb;20(1):45-54. doi: 10.1007/s10557-006-6312-4. Cardiovasc Drugs Ther. 2006. PMID: 16552473 Free article.
Effect of Antigen Valency on Autoreactive B-Cell Targeting.
van Weijsten MJ, Venrooij KR, Lelieveldt LPWM, Kissel T, van Buijtenen E, van Dalen FJ, Verdoes M, Toes REM, Bonger KM. van Weijsten MJ, et al. Among authors: van dalen fj. Mol Pharm. 2024 Feb 5;21(2):481-490. doi: 10.1021/acs.molpharmaceut.3c00527. Epub 2023 Oct 20. Mol Pharm. 2024. PMID: 37862070 Free PMC article.
Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma Engineering.
Le Gall CM, van der Schoot JMS, Ramos-Tomillero I, Khalily MP, van Dalen FJ, Wijfjes Z, Smeding L, van Dalen D, Cammarata A, Bonger KM, Figdor CG, Scheeren FA, Verdoes M. Le Gall CM, et al. Among authors: van dalen fj. Bioconjug Chem. 2021 Feb 17;32(2):301-310. doi: 10.1021/acs.bioconjchem.0c00673. Epub 2021 Jan 21. Bioconjug Chem. 2021. PMID: 33476135 Free PMC article.
Molecular Repolarisation of Tumour-Associated Macrophages.
van Dalen FJ, van Stevendaal MHME, Fennemann FL, Verdoes M, Ilina O. van Dalen FJ, et al. Molecules. 2018 Dec 20;24(1):9. doi: 10.3390/molecules24010009. Molecules. 2018. PMID: 30577495 Free PMC article. Review.
17 results